Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC |
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC, Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. |
1:2021cv01348 |
September 24, 2021 |
US District Court for the District of Delaware |
Colm F Connolly |
Jennifer L Hall |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on April 21, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 85 NOTICE OF SERVICE of Teva's Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1 - 4) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
Filing 84 NOTICE OF SERVICE of Pfizer Inc.'s Responses and Objections to Defendants' Subpoena to Produce Documents filed by Anacor Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 83 NOTICE of Subpoenas by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC (Attachments: #1 Exhibits 1-3)(Bilson, David) |
Filing 82 NOTICE of Defendants' Notice of Subpoenas by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC (Attachments: #1 Exhibit 1-6)(Bilson, David) |
Filing 81 NOTICE of Subpoena to Pfizer Inc. by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC (Attachments: #1 Exhibit 1)(Bilson, David) |
Filing 80 NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories (Nos. 5-10) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Bilson, David) |
Filing 79 MOTION for Pro Hac Vice Appearance of Attorney Matthew Ginther - filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
SO ORDERED, re #79 MOTION for Pro Hac Vice Appearance of Attorney Matthew Ginther, filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. Ordered by Judge Colm F. Connolly on 3/21/2023. (kmd) |
Pro Hac Vice Attorney Matthew Ginther for Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (jdb) |
Filing 78 NOTICE requesting Clerk to remove Ryan B. Hauer as co-counsel. Reason for request: no longer working on the case. (Bilson, David) |
Filing 77 SO ORDERED, re #76 STIPULATION TO EXTEND TIME for substantial completion of document production to February 14, 2023, filed by Dr. Reddy's Laboratories, Inc., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC, Dr. Reddys Laboratories, Ltd. Signed by Judge Colm F. Connolly on 1/25/2023. (kmd) |
Filing 76 STIPULATION TO EXTEND TIME for substantial completion of document production to February 14, 2023 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC. (Bilson, David) |
Filing 75 SO ORDERED, re #74 Stipulation of Dismissal Concerning Defendant Alkem Laboratories Ltd., filed by Anacor Pharmaceuticals, LLC, PF PRISM IMB B.V. (Party Alkem Laboratories Ltd. terminated. Attorneys Kevin M. Capuzzi and Louis Constantinou terminated.) Signed by Judge Colm F. Connolly on 1/13/2023. (kmd) |
Filing 74 STIPULATION and Order of Dismissal Concerning Defendant Alkem Laboratories Ltd. - by Anacor Pharmaceuticals, LLC, PF PRISM IMB B.V.. (Dellinger, Megan) |
Remark: The March 9, 2023 Markman Hearing is canceled per the letter at D.I. #73 stating that it is not needed. The Joint Claim Construction Brief deadline has also been terminated. (nmf) |
Filing 73 Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding claim construction. (Dellinger, Megan) |
Filing 72 NOTICE OF SERVICE of Defendants Proposed Claim Constructions filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Filing 71 NOTICE OF SERVICE of Plaintiffs' Proposed Constructions for Claim Terms Identified for Construction filed by Anacor Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 70 NOTICE OF SERVICE of Defendants' List of Claims Terms filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Filing 69 NOTICE OF SERVICE of Plaintiffs' Identification of Terms for Construction filed by Anacor Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 68 NOTICE OF SERVICE of Defendants [CONFIDENTIAL] Initial Invalidity Contentions filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Bilson, David) |
Filing 67 SO ORDERED, re #66 STIPULATION TO EXTEND TIME for Defendants to serve Invalidity Contentions and any accompanying document production to September 1, 2022 filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Signed by Judge Colm F. Connolly on 8/25/2022. (nmf) |
Filing 66 STIPULATION TO EXTEND TIME for Defendants to serve Invalidity Contentions and any accompanying document production to September 1, 2022 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Bilson, David) |
Filing 65 STIPULATION and Proposed Order to Extend Time by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC. (Bilson, David) |
SO ORDERED, re #65 Stipulation to Extend Time, filed by Dr. Reddys Laboratories, Inc., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC, Dr. Reddys Laboratories, Ltd. Ordered by Judge Colm F. Connolly on 8/10/2022. (kmd) |
Filing 64 NOTICE OF SERVICE of Plaintiffs' First Amended Paragraph 3 Disclosure of Custodians and Non-Custodial Data Sources filed by Anacor Pharmaceuticals, LLC, PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 63 NOTICE OF SERVICE of the Padagis Defendants Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-4) and Objections and Responses to Plaintiffs First Set of Requests for Production (Nos. 1-63) filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Bilson, David) |
Filing 62 STIPULATION and [Proposed] Order to Change Name and Amend Case Caption by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
SO ORDERED, re #62 Stipulation to Change Name and Amend Case Caption, filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 6/24/2022. (kmd) |
Filing 61 NOTICE OF SERVICE of Plaintiffs Anacor Pharmaceuticals, Inc. and PF Prism IMB B.V.'s Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-4) - filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 60 NOTICE OF SERVICE of Plaintiffs' Disclosure of Asserted Claims and Infringement Contentions filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 59 NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories Inc. and Dr Reddy's Laboratories Ltd.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-4) and Defendants Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd.'s Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-66) filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bilson, David) |
Filing 58 NOTICE OF SERVICE of 1. Teva's Response to Plaintiffs' First Set of Requests for Production (Nos. 1-60) 2. Teva's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-4) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Filing 57 NOTICE of OF SERVICE by Alkem Laboratories Ltd. of (i) Defendant Alkem Laboratories' Responses and Objections to Plaintiffs' First Set of Interrogatories and (ii) Defendant Alkem Laboratories' Responses to Plaintiffs' First Set of Requests for Production (Capuzzi, Kevin) |
Filing 56 NOTICE OF SERVICE of (i) Defendants Macleods Pharmaceuticals Ltd.'s and Macleods Pharma USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Individual Interrogatories (Nos. 1-4); and (ii) Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-6) filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Kirby, April) |
Filing 55 MOTION for Pro Hac Vice Appearance of Attorney Autumn Soucy - filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
Pro Hac Vice Attorney Ryan B. Hauer for Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
Pro Hac Vice Attorney Autumn Soucy for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
SO ORDERED, re #54 MOTION for Pro Hac Vice Appearance of Attorney Ryan B. Hauer, filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Ordered by Judge Colm F. Connolly on 6/8/2022. (kmd) |
SO ORDERED, re #55 MOTION for Pro Hac Vice Appearance of Attorney Autumn Soucy, filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. Ordered by Judge Colm F. Connolly on 6/8/2022. (kmd) |
Filing 54 MOTION for Pro Hac Vice Appearance of Attorney Ryan B. Hauer - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Attachments: #1 Certification of Ryan B. Hauer)(Bilson, David) |
Filing 53 NOTICE of Change of Address by Megan Elizabeth Dellinger (Dellinger, Megan) |
Filing 52 ANSWER to #45 Answer to Amended Complaint, Counterclaim, by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. (Dellinger, Megan) Modified on 5/24/2022 (ceg). |
Pro Hac Vice Attorney James W. Sanner for Padagis Israel Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
Filing 51 NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Filing 50 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendants Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. (Nos. 1-60); and (2) Plaintiffs' First Set of Interrogatories to Defendants Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. (Nos. 1-4) filed by PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 49 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendants Padagis Israel Pharmaceuticals Ltd. and Padagis, LLC (Nos. 1-63); and (2) Plaintiffs' First Set of Interrogatories to Defendants Padagis Israel Pharmaceuticals Ltd. and Padagis, LLC (Nos. 1-4) filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 48 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. (Nos. 1-61); and (2) Plaintiffs' First Set of Interrogatories to Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. (Nos. 1-4) filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 47 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (Nos. 1-66); and (2) Plaintiffs' First Set of Interrogatories to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (Nos. 1-4) filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 46 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendant Alkem Laboratories Ltd. (Nos. 1-69); and (2) Plaintiffs' First Set of Interrogatories to Defendant Alkem Laboratories Ltd. (Nos. 1-4) filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 45 ANSWER to Amended Complaint, re: #38 Amended Complaint , COUNTERCLAIM and Affirmative Defenses against Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Development, Inc..(Hoeschen, Nathan) |
Filing 44 NOTICE OF SERVICE of Plaintiffs Anacor Pharmaceuticals, Inc. and PF Prism IMB B.V.'s Responses and Objections to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-68) filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 43 NOTICE requesting Clerk to remove Christopher P. Galligan as co-counsel. Reason for request: No longer with firm. (Bilson, David) |
Filing 42 NOTICE OF SERVICE of Defendants Padagis Israel Pharmaceuticals Ltd and Padagis, LLC's [CONFIDENTIAL] Production of ANDA Documents Pursuant to Paragraph 4 of the Scheduling Order (D.I. 22) filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Bilson, David) |
CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's #Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. 652(b). (Taylor, Daniel) |
Filing 41 NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.'s [CONFIDENTIAL] Production of ANDA Documents Pursuant to Paragraph 4 of the Scheduling Order (D.I. 22) filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bilson, David) |
Filing 40 NOTICE of Service of ANDA document production by Alkem Laboratories Ltd. (Capuzzi, Kevin) |
Filing 39 NOTICE OF SERVICE of Defendants' First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-68) filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Bilson, David) |
Filing 38 First AMENDED COMPLAINT against Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc.- filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Attachments: #1 Exhibits A-D)(Dellinger, Megan) |
Filing 37 SO ORDERED, re #36 Stipulation to File Amended Complaint Against the Teva Defendants, filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 3/28/2022. (kmd) |
Filing 36 STIPULATION and [Proposed] Order to File Amended Complaint Against the Teva Defendants by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Attachments: #1 First Amended Teva Complaint, #2 Exhibits A-D to First Amended Teva Complaint, #3 Exhibit 2)(Dellinger, Megan) |
Filing 35 NOTICE OF SERVICE of Initial Disclosures of Defendants Padagis Israel Pharmaceuticals Ltd and Padagis, LLC Pursuant to Fed. R. Civ. P. 26(a)(1) and Paragraph 3 of the Default Standard for Discovery filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Bilson, David) |
Filing 34 NOTICE OF SERVICE of (1) Plaintiffs' Paragraph 3 Initial Disclosures; and (2) Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Dellinger, Megan) |
Filing 33 NOTICE of Service by Alkem Laboratories Ltd. of Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and the Delaware Default Standard for Discovery (Capuzzi, Kevin) |
Filing 32 NOTICE OF SERVICE of Defendants Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
Filing 31 NOTICE OF SERVICE of DRL's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and DRL's Paragraph 3 Initial Disclosures filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bilson, David) |
Filing 30 NOTICE OF SERVICE of (i) Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Rule 26(a)(1) Initial Disclosures; and (ii) Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Seaman, John) |
Filing 29 PROPOSED ORDER -- Protective Order -- by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
SO ORDERED, re #29 Proposed Protective Order, filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 3/18/2022. (kmd) |
Filing 28 SO ORDERED, re #27 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 23, 2022, filed by Dr. Reddys Laboratories, Inc., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC, Dr. Reddys Laboratories, Ltd. Signed by Judge Colm F. Connolly on 3/17/2022. (kmd) |
Filing 27 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 23, 2022 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Padagis Israel Pharmaceuticals Ltd., Padagis, LLC. (Bilson, David) |
Filing 26 SO ORDERED, re #25 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 16, 2022, filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 3/2/2022. (kmd) |
Filing 25 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 16, 2022 - filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
Pro Hac Vice Attorney Louis Constantinou for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) |
Filing 24 MOTION for Pro Hac Vice Appearance of Attorney Louis Constantinou - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) |
SO ORDERED, re #24 MOTION for Pro Hac Vice Appearance of Attorney Louis Constantinou, filed by Alkem Laboratories Ltd. Ordered by Judge Colm F. Connolly on 2/22/2022. (kmd) |
Filing 23 ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 2/16/2022. (ceg) |
Filing 22 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery matters and the protective order. Joinder of Parties due by 3/31/2023. Amended Pleadings due by 3/31/2023. Fact Discovery completed by 6/16/2023. Expert Discovery due by 12/20/2023. Joint Claim Construction Brief due by 2/16/2023. A Markman Hearing is set for 3/9/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 2/29/2024. A Final Pretrial Conference is set for 3/21/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/8/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/16/2022. (nmf) |
The 2/17/2022 Scheduling Conference is canceled per the filing and entry of the unopposed Scheduling Order. (nmf) |
ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (#daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 2/16/2022. (Taylor, Daniel) |
CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
Filing 21 PROPOSED ORDER -- Scheduling Order -- by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Attachments: #1 Letter to The Honorable Colm F. Connolly)(Dellinger, Megan) |
Pro Hac Vice Attorneys Corey Weinstein and A. Neal Seth for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
SO ORDERED, re #20 MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth, Esq. and Corey Weinstein, Esq. of Wiley Rein LLP, filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc. Ordered by Judge Colm F. Connolly on 1/31/2022. (kmd) |
Filing 20 MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth, Esq. and Corey Weinstein, Esq. of Wiley Rein LLP - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: #1 Certification of A. Neal Seth, Esq., #2 Certification of Corey Weinstein, #3 Text of Proposed Order)(Seaman, John) |
Filing 19 ORDER: These cases are consolidated for all purposes. Civil Action No. 21-1348-CFC shall be designated as the lead case and all future filings shall be made in Lead Case No. 21-1348-CFC ONLY. Order Setting Telephonic Scheduling Conference:( A Scheduling Conference is set for 2/17/2022 at 11:30 AM before Judge Colm F. Connolly.) If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 1/10/2022. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(nmf) |
Filing 18 Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding request for consolidation of cases - re (14 in 1:21-cv-01349-CFC, 14 in 1:21-cv-01349-CFC, 17 in 1:21-cv-01353-CFC, 17 in 1:21-cv-01353-CFC, 16 in 1:21-cv-01348-CFC, 16 in 1:21-cv-01348-CFC, 15 in 1:21-cv-01351-CFC, 15 in 1:21-cv-01351-CFC, 16 in 1:21-cv-01350-CFC, 16 in 1:21-cv-01350-CFC) Order,,, Set Deadlines,,. (Blumenfeld, Jack) |
Filing 17 ANSWER to #13 Answer to Complaint, Counterclaim - by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Blumenfeld, Jack) |
Filing 16 ORDER: IT IS ORDERED that, on or before January 7, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/7/2022.) Signed by Judge Colm F. Connolly on 12/3/2021. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(nmf) |
Pro Hac Vice Attorney Samuel J. Ruggio for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
SO ORDERED, re #15 MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio, Esquire, filed by Alkem Laboratories Ltd. Ordered by Judge Colm F. Connolly on 11/19/2021. (kmd) |
Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio, Esquire - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) |
Pro Hac Vice Attorneys Elizabeth Chang, Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, and C. Sebastian Zonte for Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(srs) |
Filing 14 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) |
Filing 13 ANSWER to #1 Complaint, , COUNTERCLAIM against Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. by Alkem Laboratories Ltd..(Capuzzi, Kevin) |
Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, C. Sebastian Zonte and Elizabeth Chang - filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
SO ORDERED, re (9 in 1:21-cv-01349-CFC, 12 in 1:21-cv-01348-CFC, 10 in 1:21-cv-01353-CFC, 10 in 1:21-cv-01351-CFC, 10 in 1:21-cv-01350-CFC) MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, C. Sebastian Zonte and Elizabeth Chang filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 10/14/2021. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC (kmd) |
Pro Hac Vice Attorney Michael S. Weinstein,Manish K. Mehta for Alkem Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta, Esquire filed by Alkem Laboratories Ltd., #11 MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein, Esquire filed by Alkem Laboratories Ltd. Ordered by Judge Colm F. Connolly on 10/13/2021. (kmd) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to File Answer re #1 Complaint filed by Alkem Laboratories Ltd. Ordered by Judge Colm F. Connolly on 10/13/2021. (kmd) |
Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein, Esquire - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) |
Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta, Esquire - filed by Alkem Laboratories Ltd.. (Capuzzi, Kevin) |
Filing 9 STIPULATION and Proposed Order for Extension of Time to File Answer re #1 Complaint, - filed by Alkem Laboratories Ltd. (Capuzzi, Kevin) Modified on 10/13/2021 (kmd). |
Filing 8 NOTICE of Appearance by Kevin M. Capuzzi on behalf of Alkem Laboratories Ltd. (Capuzzi, Kevin) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC (rjb) |
Filing 7 AFFIDAVIT of Service for Summons, Complaint and related papers served on Alkem Laboratories Ltd. on September 28, 2021, filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
Filing 6 Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Ltd. on 9/27/2021. (myr) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent PF Prism C.V. for PF PRISM IMB B.V.; Corporate Parent Pfizer Inc. for Anacor Pharmaceuticals, Inc. filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. (myr) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,451 B2 ;8,168,614 B2 ;8,501,712 B2 ;9,682,092 B2. (myr) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/23/2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/14/2024**. (myr) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
Filing 1 COMPLAINT filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3707105.) - filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.